BRL: Barr Pharmaceuticals Merger News and Arbitrage Profit - MergerInvesting.com

2008-12-02 06:24:43
All stock information and news updated each evening.
If you would like real time stock quotes, profit calculations and news, please sign in or become a member.
Listed Closing Values do not include regular dividends.

Symbol Announced Date Closing Value Last Price Closing Date Profit Annualized Profit
BRL 2008-07-18 $65.83 $62.84 2008-12-31 4.77 % 59.98 %

Additional Information
If the merger is completed, Barr Pharmaceuticals shareholders will receive $39.90 in cash and 0.6272 Teva ADRs for each share held.

Barr Pharmaceuticals Merger News:

DateUpdate
2008-07-18 Teva Pharmaceutical to Buy Barr Pharmaceuticals for $7.46 Billion
2008-08-03 Watch for More Coming Biotech Acquisitions (at Seeking Alpha)
2008-08-03 S&P 500s Best and Worst Net Income Change (at Seeking Alpha)
2008-08-19 Barr Pharma a Hold on Teva Buyout (Zacks.com)
2008-09-03 Teva and Barr Receive FTC Request for Additional Information (Business Wire)
2008-10-13 Barr Pharma Deal Should Close (Zacks.com)
2008-10-16 Barr Announces Date for Special Shareholder Meeting (PR Newswire)
2008-10-27 Teva and Barr Provide Update on Acquisition (Business Wire)
2008-11-21 Barr Shareholders Approve Pending Teva Acquisition (PR Newswire)


View Closing Conditions for the Barr Pharmaceuticals (BRL) Merger



View Financing Conditions for the Barr Pharmaceuticals (BRL) Merger






MergerInvesting.com is an information service and is not a recommendation, an offer, or a solicitation of an offer to buy or sell securities. The information and data on this website are provided on an "AS IS, AS AVAILABLE" basis without warranty of any kind. MergerInvesting.com makes no guarantee as to the accuracy or completeness of this information. All information is provided for informational purposes only, and MergerInvesting.com shall not be liable for any errors or omissions, or for any action taken because of this information. At any time MergerInvesting.com's affiliates may maintain long or short positions in the securities listed in this report.

Copyright 2008 MergerInvesting.com

Privacy Policy